Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus minocycline in the treatment of papulopustular rosacea
2010-021150-19Phase 3Active
- Sponsor
- Amsterdam UMC Department of Dermatology
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in papulopustular rosacea comparing Efracea 40 mg with Minocycline 100 mg (2 arms). Primary endpoints: Change in lesion count at week 16 and Change in RosaQoL score at week 16. Started Jul 2010; status: active.
02
Drugs
doxycyclineminocycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2010-021150-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021150-19.